ReShape Lifesciences Inc - ESG Rating & Company Profile powered by AI
Detailed Sustainability analysis of ReShape Lifesciences Inc are reached by signing in. The report of ReShape Lifesciences Inc employs data points from across the web and also from available disclosures by ReShape Lifesciences Inc. Other companies in the rating peer group for ReShape Lifesciences Inc are shown below.
ReShape Lifesciences Inc in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 0.0 and governance score of 5.3.
1.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
... | ... | ... | |
221 | Optomed Plc | 1.9 | Low |
221 | Vitalhub Corp | 1.9 | Low |
225 | ReShape Lifesciences Inc | 1.8 | Low |
225 | ATW Tech Inc | 1.8 | Low |
225 | Medx Health Corp | 1.8 | Low |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does ReShape Lifesciences Inc have an accelerator or VC vehicle to help deliver innovation?
Does ReShape Lifesciences Inc disclose current and historical energy intensity?
Does ReShape Lifesciences Inc report the average age of the workforce?
Does ReShape Lifesciences Inc reference operational or capital allocation in relation to climate change?
Does ReShape Lifesciences Inc disclose its ethnicity pay gap?
Does ReShape Lifesciences Inc disclose cybersecurity risks?
Does ReShape Lifesciences Inc offer flexible work?
Does ReShape Lifesciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does ReShape Lifesciences Inc disclose the number of employees in R&D functions?
Does ReShape Lifesciences Inc conduct supply chain audits?
Does ReShape Lifesciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does ReShape Lifesciences Inc conduct 360 degree staff reviews?
Does ReShape Lifesciences Inc disclose the individual responsible for D&I?
Does ReShape Lifesciences Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does ReShape Lifesciences Inc disclose current and / or historical scope 2 emissions?
Does ReShape Lifesciences Inc disclose water use targets?
Does ReShape Lifesciences Inc have careers partnerships with academic institutions?
Did ReShape Lifesciences Inc have a product recall in the last two years?
Does ReShape Lifesciences Inc disclose incidents of discrimination?
Does ReShape Lifesciences Inc allow for Work Councils/Collective Agreements to be formed?
Has ReShape Lifesciences Inc issued a profit warning in the past 24 months?
Does ReShape Lifesciences Inc disclose parental leave metrics?
Does ReShape Lifesciences Inc disclose climate scenario or pathway analysis?
Does ReShape Lifesciences Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does ReShape Lifesciences Inc disclose the pay ratio of women to men?
Does ReShape Lifesciences Inc support suppliers with sustainability related research and development?
Does ReShape Lifesciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does ReShape Lifesciences Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is ReShape Lifesciences Inc involved in embryonic stem cell research?
Does ReShape Lifesciences Inc disclose GHG and Air Emissions intensity?
Does ReShape Lifesciences Inc disclose its waste policy?
Does ReShape Lifesciences Inc report according to TCFD requirements?
Does ReShape Lifesciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does ReShape Lifesciences Inc disclose energy use targets?
Does ReShape Lifesciences Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does ReShape Lifesciences Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for ReShape Lifesciences Inc
These potential risks are based on the size, segment and geographies of the company.
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.